Beate Hauglann1, Jūratė Šaltytė Benth, Sophie D Fosså, Alv A Dahl. 1. National Resource Center for Late Effects, Department of Oncology, Oslo University Hospital, Radiumhospitalet and University of Oslo, Oslo, Norway. beate.hauglann@gmail.com
Abstract
PURPOSE: The aims of this cohort study were to explore various longitudinal aspects of employment and disability pension due to permanently reduced work ability among women with breast cancer and to investigate the impact of breast cancer on income. PATIENTS AND METHODS: In a national register-based controlled cohort study from Norway, 1,548 women diagnosed with breast cancer (all stages) between 1992 and 1996 at the age 45-54 years and 1,548 cancer-free women matched for age, municipality and civil status were followed for up to 14 years. Medical data from the Cancer Registry of Norway were linked with longitudinal data on employment, social security benefits and socio-demography collected from other national official registries. RESULTS: Compared to cancer-free controls, breast cancer patients were significantly more likely to receive disability pension (hazard ratio (HR) 2.7, 95% CI 2.3-3.2) after adjustment for unmatched socio-demographic variables (education, income and children <18 years in the household). Adjusted HR in breast cancer stage I patients was 1.8 (95% CI 1.5-2.3) and 3.0 (95% CI 2.4-3.8) in stage II/III patients compared to controls. The risk increased with mastectomy compared to breast-conserving surgery (HR 1.5, 95% CI 1.2-1.9). At the end of the observation period, employment rates were higher in non-disabled patients than in non-disabled controls (82% vs. 77%, p = 0.008). Working breast cancer patients experienced a temporary negative effect on employment income. CONCLUSION: A considerable proportion of women with breast cancer will over time experience permanently reduced work ability and become disability pension holders. In case of reduced work ability in breast cancer survivors, medical personel caring for them should consider and discuss with them rehabilitation and workplace adjustment in order to prevent early disability pension.
PURPOSE: The aims of this cohort study were to explore various longitudinal aspects of employment and disability pension due to permanently reduced work ability among women with breast cancer and to investigate the impact of breast cancer on income. PATIENTS AND METHODS: In a national register-based controlled cohort study from Norway, 1,548 women diagnosed with breast cancer (all stages) between 1992 and 1996 at the age 45-54 years and 1,548 cancer-free women matched for age, municipality and civil status were followed for up to 14 years. Medical data from the Cancer Registry of Norway were linked with longitudinal data on employment, social security benefits and socio-demography collected from other national official registries. RESULTS: Compared to cancer-free controls, breast cancerpatients were significantly more likely to receive disability pension (hazard ratio (HR) 2.7, 95% CI 2.3-3.2) after adjustment for unmatched socio-demographic variables (education, income and children <18 years in the household). Adjusted HR in breast cancer stage I patients was 1.8 (95% CI 1.5-2.3) and 3.0 (95% CI 2.4-3.8) in stage II/III patients compared to controls. The risk increased with mastectomy compared to breast-conserving surgery (HR 1.5, 95% CI 1.2-1.9). At the end of the observation period, employment rates were higher in non-disabled patients than in non-disabled controls (82% vs. 77%, p = 0.008). Working breast cancerpatients experienced a temporary negative effect on employment income. CONCLUSION: A considerable proportion of women with breast cancer will over time experience permanently reduced work ability and become disability pension holders. In case of reduced work ability in breast cancer survivors, medical personel caring for them should consider and discuss with them rehabilitation and workplace adjustment in order to prevent early disability pension.
Authors: Arnstein Mykletun; Simon Overland; Alv A Dahl; Steinar Krokstad; Ottar Bjerkeset; Nicholas Glozier; Leif E Aarø; Martin Prince Journal: Am J Psychiatry Date: 2006-08 Impact factor: 18.112
Authors: Kathleen Oberst; Cathy J Bradley; Joseph C Gardiner; Maryjean Schenk; Charles W Given Journal: J Cancer Surviv Date: 2010-06-12 Impact factor: 4.442
Authors: Michael Feuerstein; Briana L Todd; Michal C Moskowitz; Gina L Bruns; Mallori R Stoler; Thomas Nassif; Xinhua Yu Journal: J Cancer Surviv Date: 2010-10-14 Impact factor: 4.442
Authors: A G E M de Boer; J H A M Verbeek; E R Spelten; A L J Uitterhoeve; A C Ansink; T M de Reijke; M Kammeijer; M A G Sprangers; F J H van Dijk Journal: Br J Cancer Date: 2008-03-18 Impact factor: 7.640
Authors: Kathleen D Lyons; Jay G Hull; Peter A Kaufman; Zhongze Li; Janette L Seville; Tim A Ahles; Alice B Kornblith; Mark T Hegel Journal: J Psychosoc Oncol Date: 2015-02-10
Authors: Beate Hauglann; Jūratė Saltytė Benth; Sophie D Fosså; Kjell M Tveit; Alv A Dahl Journal: Support Care Cancer Date: 2014-05-13 Impact factor: 3.603
Authors: Peh Joo Ho; Mikael Hartman; Sofie A M Gernaat; Alex R Cook; Soo Chin Lee; Leon Hupkens; Helena M Verkooijen Journal: Support Care Cancer Date: 2018-03-06 Impact factor: 3.603
Authors: Li Wang; Brian Y Hong; Sean A Kennedy; Yaping Chang; Chris J Hong; Samantha Craigie; Henry Y Kwon; Beatriz Romerosa; Rachel J Couban; Susan Reid; James S Khan; Michael McGillion; Victoria Blinder; Jason W Busse Journal: J Clin Oncol Date: 2018-05-14 Impact factor: 44.544
Authors: Ellen Burke Beckjord; Kerry A Reynolds; G J van Londen; Rachel Burns; Reema Singh; Sarah R Arvey; Stephanie A Nutt; Ruth Rechis Journal: J Psychosoc Oncol Date: 2014
Authors: Allegra W Timperi; Isaac Joshua Ergas; David H Rehkopf; Janise M Roh; Marilyn L Kwan; Lawrence H Kushi Journal: Psychooncology Date: 2012-08-22 Impact factor: 3.894